In an interview with FE Healthcare, Shiva Sriram, President of Molbio Diagnostics, discussed the growing role of point-of-care molecular diagnostics in decentralizing healthcare. He outlined how the WHO-endorsed Truenat platform has enabled early, accessible testing for TB and other infectious diseases, especially in rural and underserved areas. Sriram noted that Truenat’s global adoption has positioned India as a serious innovator in med-tech. He also highlighted Molbio’s broader vision to expand into AI-driven diagnostics and support Indian healthcare startups through its EDGE accelerator and Center of Excellence in Bangalore.